Who is sponsoring NCT07475520?

NCT07475520 is sponsored by Cairo University.

What condition does NCT07475520 study?

NCT07475520 studies Neuropathic Pain Induced by Mastectomy.

What drugs are being tested in NCT07475520?

Interventions: Lidocaine 2%, Lidocaine.

What is the status of NCT07475520?

NCT07475520 is currently COMPLETED.

Last reviewed 2026-03-16 · How we verify

Lidocaine IV Injection With Different Doses for Patients With Neuropathic Pain After Mastectomy

NCT07475520 NA COMPLETED

cancer has become the most common malignancy affecting women worldwide, and its incidence is increasing annually. According to the Global Cancer Observatory (GLOBOCAN) 2020 published by the International Agency for Research on Cancer of the World Health Organization, female breast cancer is the cancer with the highest number of new cases worldwide significant number of patients experiencing moderate to severe acute pain (30-50%) and developing chronic post-surgical pain (CPSP) (25-68%)

Details

Lead sponsor	Cairo University
Phase	NA
Status	COMPLETED
Enrolment	30
Start date	Mon Jul 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Neuropathic Pain Induced by Mastectomy

Interventions

Lidocaine 2%
Lidocaine

Countries

Egypt